PRODUCT Properties
| Melting point: | >300 °C(lit.) |
| Boiling point: | 411.43°C (rough estimate) |
| Density | 1.1992 (rough estimate) |
| refractive index | 1.5906 (estimate) |
| solubility | soluble50mg/mL, clear, colorless to faintly yellow (DMF:MeOH(2:1)) |
| pka | 8.37±0.10(Predicted) |
| form | Solid |
| color | White to Off-White |
| Water Solubility | 36mg/L(37 ºC) |
Description and Uses
5-(4-Hydroxyphenyl)-5-phenylhydantoin was used in enantiomeric separation of chiral pharmaceuticals using a teicoplanin chiral stationary phase by aqueous and non-aqueous packed capillary electrochromatography. It was used as internal standard in determination of phenylbutazone and its metabolite oxyphenbutazone in human plasma by GLC.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 2 |
| RTECS | MU2485000 |
